The case for a broader, societal perspective in health technology assessment has been building for years, but so have the arguments against it.
Grace Hampson is joined by Chris Skedgel, a Director at OHE, to dig into one of health economics’ most contested methodological debates: what are health systems trying to achieve through health technology assessments (HTA)? And whose perspective should they adopt in doing so?
They’ll discuss:
- Why health technology assessment has traditionally focused on patient health and healthcare costs — and whether that’s still fit for purpose
- The case for including carer impacts, value of time, and productivity in assessments of value
- The biggest arguments against a societal perspective in HTA— and how to respond to them
- What the recent HEMA report got right, and where it may have been too cautious
Speakers
Listen to the episode
Never miss an episode
Subscribe to our mailing list to get the latest episode

